InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Melnick David A., Directeur Médical. Director active across 1 companies, notably Spero Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
038,014 shares0
Common Stock
SEC:0000899243-22-004594·
038,014 shares0
Common Stock
SEC:0000899243-22-004594:0·
024,067 shares0
Common Stock
SEC:0000899243-21-034503·
024,067 shares0
Common Stock
SEC:0000899243-21-034503:0·
4 of 4 declarations
About Melnick David A.
David A. Melnick serves as Chief Medical Officer at Spero Therapeutics, Inc. In this role, he is responsible for leading the company's medical initiatives and clinical research. With a strong background in the pharmaceutical sector, David contributes to innovation and treatment improvement. His leadership is essential in ensuring that Spero Therapeutics adheres to ethical and scientific standards.
